A carregar...
Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
Scleromyxedema is a rare and progressive disease that currently has no standard treatment. Triplet therapy with lenalidomide, bortezomib, and dexamethasone can be an effective therapy for scleromyxedema, especially in patients with refractory or relapsed disease.
Na minha lista:
| Publicado no: | Clin Case Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752349/ https://ncbi.nlm.nih.gov/pubmed/33363876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3302 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|